Answers are grounded in this paper and cite their sources.
In gram-negative bacteria, glycerophospholipids (GPLs) and lipopolysaccharide (LPS) are built from a shared pool of fatty acids and must be made in balance for the outer membrane to assemble correctly. PlsX and PlsY provide an auxiliary route to lysophosphatidic acid, a precursor of GPL synthesis. Either enzyme is dispensable, yet loss of both is lethal, indicating roles beyond GPL production. PlsX has one such role, preventing the accumulation of long-chain acyl-acyl carrier protein species that inhibit fatty acid synthesis. Here, we show that PlsY, a glycerol-3-phosphate 1- O- acyltransferase , has a regulatory function in LPS synthesis. We confirm that PlsY interacts directly with YejM, which, together with the adaptor protein LapB and the protease FtsH, controls both the abundance and the activity of LpxC, the enzyme that catalyzes the first committed step of LPS synthesis. Deleting plsY partially rescued the growth, antibiotic sensitivity, and LPS defects of the yejM569 mutant, which cannot sense LPS, but did not rescue other mutants with reduced LPS synthesis or defective LPS transport. Loss of PlsY also restored steady-state LpxC to wild-type levels in the yejM569 background. When fatty acid synthesis was inhibited, plsY mutants produced more LPS than wild type, suggesting that PlsY restrains LPS synthesis when fatty acids are scarce. These findings establish PlsY as more than a biosynthetic enzyme, placing it at the intersection of GPL metabolism and LPS regulation. IMPORTANCE The gram-negative outer membrane is a formidable barrier that resists many antimicrobial compounds and makes these bacteria difficult to treat clinically. The barrier is made of glycerophospholipids and lipopolysaccharide, whose synthesis must remain balanced for the membrane to assemble correctly. Here, we describe a regulatory role for the Escherichia coli enzyme PlsY beyond its known function in glycerophospholipid synthesis. Our findings suggest that PlsY signals to YejM, a protein that helps control how much lipopolysaccharide the cell makes by regulating LpxC, a leading target for antibiotic development. This link identifies a new way that gram-negative bacteria balance production of the two major lipid classes required to build their outer membrane.
No takes yet. Share an insight, caveat, or question.
Rex et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: